31 October–5 November 2027
Montréal Convention Centre
Let’s become partners.
The XXVI FIGO World Congress of Gynecology and Obstetrics offers an exceptional platform for organisations to showcase their work to more than 8,000 delegates, including obstetricians, gynaecologists, researchers, policymakers and healthcare professionals from across the globe.
The Congress provides an environment to build new connections, strengthen existing relationships, and support initiatives to advance women’s health and rights worldwide.
Partner with us to engage with a global community and help shape a safer and healthier future for women and girls around the world.
The FIGO Montréal 2027 sponsorship and exhibition prospectus is now available.
Register your interest below to access the prospectus and explore partnership opportunities to connect with the global women’s health community at FIGO Montréal 2027.
Maternal fetal health
Clinical obstetrics
Reproductive medicine
Contraception and family planning
Women’s cancer
Benign surgery
Urogynaecology
Non-surgical gynaecology
Leader: Professor Liona Poon, Hong Kong
1.1 Prenatal diagnosis, genetics, therapy and surgery
1.2 Nutrition in pregnancy and breastfeeding
1.3 Ultrasound in pregnancy
1.4 Infections, vaccination and anaemia in pregnancy
1.5 Preeclampsia and hypertensive disorders of pregnancy, including long-term health
Leader: Professor Fionnuala McAuliffe, Ireland
2.1 Obstetric emergencies, including post-partum haemorrhage (PPH) and sepsis
2.2 Operative obstetrics, including c-section, operative vaginal delivery and perineal trauma
2.3 Antenatal, postnatal and neonatal care
2.4 Midwifery care
2.5 Preterm birth and stillbirth
2.6 Maternal mortality
Leader: Dr Megan Wasson, USA
3.1 Urogynaecology, including pelvic organ prolapse and incontinence
3.2 Chronic pelvic pain
3.3 Fibroids, endometriosis and adenomyosis
3.4 Minimal access surgery, laparoscopy, robotics and hysteroscopy
3.5 Fistula prevention and treatment
3.6 Breast disease
3.7 Gender-affirming care
Leader: Dr Aparna Sridhar, USA
4.1 Contraception and family planning
4.2 Abortion care
4.3 Adolescent health
4.4 Sexual health and STI/HIV prevention
4.5 Women facing crisis
4.6 Female genital mutilation
Leader: Professor Anis Feki, Tunisia / Switzerland
5.1 Fertility
5.2 Innovation in reproductive technology
5.3 Environmental challenges
5.4 Legal and ethical aspects of human reproduction
5.5 Endometriosis and adenomyosis
Leader: Professor Etsuko Miyagi, Japan
6.1 Cervical cancer and HPV
6.2 Vaginal and vulvar cancers
6.3 Ovarian and uterine cancers
6.4 Breast cancer
6.5 Genetics, screening and prevention
6.6 Diagnosis and management of gynaecological malignancies
Leader: Professor Basil Tarlatzis, Greece
7.1 Menstrual health
7.2 Menopause and perimenopause
7.3 Diabetes
7.4 PCOS/PMOS
7.5 Nutrition
7.6 Obesity
We invite you to contact our partnership manager to discuss how your organisation can support and participate in FIGO Montréal 2027.
Our team will work with you to develop a tailored partnership aligned with your objectives and budget, with a range of flexible opportunities available.
AIFA procedure – Italian pharmaceutical companies only
The agency officially appointed as the collector for the AIFA pre-application for the FIGO Congress is:
Fargo International di Giulia Cambria
Ref. Giulia Cambria
info@fargointernational.it
Tel. +39333 5202862